The inhibitors of the tissue factor:factor VII pathway

Thrombosis Research

Volumn 106, Issue 3, 2002, Pages

  Golino, Paolo ^a  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

Author keywords

Coagulation; Hemostasis; Thrombosis; Tissue factor:factor VII complex

Indexed keywords

BLOOD CLOTTING FACTOR 7; BLOOD CLOTTING FACTOR 8A; CELL SURFACE PROTEIN; CHLOROMETHYL KETONE; FIBRIN; FIBRINOGEN; KETONE DERIVATIVE; PROCOAGULANT; PROTHROMBIN; THROMBIN; THROMBOPLASTIN; TISSUE FACTOR PATHWAY INHIBITOR; UNCLASSIFIED DRUG; BLOOD CLOTTING INHIBITOR;

ARTERY WALL; BLEEDING TENDENCY; BLOOD CLOTTING; BLOOD VESSEL INJURY; CELL PROLIFERATION; ENZYME ACTIVITY; HEMOSTASIS; HUMAN; IN VIVO STUDY; INFLAMMATION; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN STRUCTURE; REVIEW; SIGNAL TRANSDUCTION; THROMBOGENESIS; DRUG ANTAGONISM; DRUG EFFECT; METABOLISM; PHYSIOLOGY; PROTEIN BINDING; THROMBOSIS;

BLOOD COAGULATION; BLOOD COAGULATION FACTOR INHIBITORS; FACTOR VII; HUMANS; PROTEIN BINDING; THROMBOPLASTIN; THROMBOSIS;

EID: 0036588702     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0049-3848(02)00079-8     Document Type: Article

References (64)

1. Dahlbäch B. Blood coagulation. Lancet. 355:2000;1627-1632.
2. Morrissey J.H., Macik B.G., Neuenschwander P.F., Comp P.C. Quantitation of activated factor VII levels in plasma using a tissue factor mutant selectively deficient in promoting factor VII activation. Blood. 81:1993;734-744.
3. Nemerson V., Repke D. Tissue factor accelerates the activation of coagulation factor VII: the role of a hi functional coagulation cofactor. Thromb. Res. 40:1985;351-358.
4. Rao L.V., Rapaport S.I. Activation of factor VII bound to tissue factor: a key early step in the tissue factor pathway of blood coagulation. Proc. Natl. Acad. Sci. U. S. A. 85:1988;6687-6691.
5. Radcliffe R., Nemerson V. Activation and control of factor VII by activated factor X and thrombin: isolation and characterization of a single chain form of factor VII. J. Biol. Chem. 250:1975;388-395.
6. Kisiel W., Fujikawa K., Davie E.W. Activalion of bovine factor VII (proconverlin) by factor XIIa (activated Hageman factor). Biochemistry. 16:1977;4189-4194.
7. Seligsohn U., Osterud B., Brown S.F., Griffin J.H., Rapaport S.I. Activation of human factor VII in plasma and in purified systems: roles of activated factor IX, kallikrein, and activated factor XII. J. Clin. Invest. 64:1979;1056.
8. Masys D.R., Bajaj S.P., Rapaport S.I. Activation of human factor VII by activated factors IX and X. Blood. 60:1982;1143-1150.
9. Tsujioka H., Suehiro A., Kakishita E. Activation of coagulation factor VII by tissue-type plasminogen activator. Am. J. Hematol. 61:1999;34-39.
10. Nakagaki T., Foster D.C., Berkner K.L., Kisiel W. Initiation of the extrinsic pathway of blood coagulation: evidence for the tissue factor dependent autoactivation of human coagulation factor VII. Biochemistry. 30:1991;10819-10824.
11. Neuenschwander P.F., Fiore M.M., Morrissey J.H. Factor VII autoactivation proceeds via interaction of distinct protease-cofactor and zymogen-cofactor complexes. Implications of a two-dimensional enzyme kinetic mechanism. J. Biol. Chem. 268:1993;21489-21492.
12. Broze G.J. Jr., Leykam J.E., Schwartz B.D., Miletich J.P. Purification of human brain tissue factor. J. Biol. Chem. 260:1985;10917-10920.
13. Paborsky L.R., Tate K.M., Harris R.J., Yansura D.G., Band L., McCray G.et al. Purification of recombinant human tissue factor. Biochemistry. 28:1989;8072-8077.
14. Bazan J.F. Structural design and molecular evolution of a cytokine receptor superfamily. Proc. Natl. Acad. Sci. U. S. A. 87:1990;6934-6938.
15. Paborsky L.R., Caras J.W., Fisher K.L., Gorman C.M. Lipid association, but not the transmembrane domain, is required for tissue factor activity. Substitution of the transmembrane domain with a phosphatidylinositol anchor. J. Biol. Chem. 266:1991;21911-21916.
16. Pedersen A.H., Nordfang O., Norris F., Wilbeig F.C., Christensen P.M., Mueller K.B. Recombinant human extrinsic pathway inhibitor. Production, isolation, and characterization of its inhibitory activity on tissue factor-initiated coagulation reactions. J. Biol. Chem. 265:1990;16786-16793.
17. Ruf W., Rehemtulla A., Morrissey J.H., Edgington T.S. Phospholipid-independent and -dependent interactions required for tissue factor receptor and cofactor function. J. Biol. Chem. 266:1991;2158-2166.
18. Payne M.A., Neuenschwander P.F., Johnson A.E., Morrissey J.H. Effect of soluble tissue factor on the kinetic mechanism of factor VIIa: enhancement of p-guanidinobenzoate substrate hydrolysis. Biochemistry. 35:1996;7100-7106.
19. Huang Q.L., Neuenschwander P.F., Rezaie A.R., Monrissey J.H. Substrate recognition by tissue factor-factor VIta - evidence for interaction of residues Lys 165 and Lys 166 of tissue factor with the 4-carboxyglutamate-rich domain of factor X. J. Biol. Chem. 271:1996;21752-21757.
20. Maynard J.R., Dreyer B.E., Stemerman M.B., Pitlick F.A. Tissue-factor coagulant activity of cultured human endothelial and smooth muscle cells and fibroblasts. Blood. 50:1977;387-396.
21. Drake T.A., Rut W., Morrissey J.H., Edgingtun T.S. Functional tissue factor is entirely cell surface expressed on LPS stimulated human blood monocytes and a constitutively tissue factor producing neoplastic cell line. J. Cell. Biol. 109:1989;389-395.
22. Bach R., Rifkin D.B. Expression of tissue factor procoagulant activity: regulation by cytosolic calcium. Proc. Natl. Acad. Sci. U. S. A. 87:1990;6995-6999.
23. Wilcox J.N., Smith K.M., Schwartz S., Gordon D. Localization of tissue factor in the normal vessel wall and in the atherosclerotic plaque. Proc. Natl. Acad. Sci. U. S. A. 86:1989;2839-2843.
24. Jander S., Sitzer M., Wendt A., Schroeter M., Buchkremer M., Siebler M., Muller W., Sandmann W., Stoll G. Expression of tissue factor in high-grade carotid stenosis: association with plaque destabilization. Stroke. 32:2001;850-854.
25. Toschi V., Gallo R., Lettino M., Fallon J.T., Gertz D., Fernandez-Ortiz A., Chesebro J.H., Badimon L., Nemerson Y., Fuster V., Badimon J.J. Tissue factor modulates the thrombogenicity of human atherosclerotic plaques. Circulation. 95:1997;594-599.
26. Annex B.H., Denning S.M., Channon K.M., Sketch M.H., Stack R.S., Morrisey J.H., Peters K.G. Differential expression of tissue factor protein in directional atherectomy specimens from patients with stable and unstable coronary syndromes. Circulation. 91:1995;619-622.
27. Ardissino D., Merlini P.A., Ariens R., Coppola R., Bramucci E., Mannucci P.M. Tissue-factor antigen and activity in human coronary atherosclerotic plaques. Lancet. 349:1997;769-771.
28. Ragni M., Golino P., Cirillo P., Scognamiglio A., Piro O., Esposito N., Battaglia C., Ponticeli P., Ramunno L., Chiariello M. Endogenous tissue factor pathway inhibitor modulates thrombus formation in an in vivo model of rabbit carotid artery stenosis and endothelial injury. Circulation. 102:2000;113-117.
29. Ravera A., Golino P., Piscione F., Leosco D., Cirillo P., Ragni M., Ezban M., D'Andrea D., Chiariello M. Activation of tissue factor-dependent coagulation pathway in patients with acute myocardial infarction. J. Am. Coll. Cardiol. 35(Suppl. A):2000;406.
30. Soejima H., Ogawa H., Yasue H., Kaikita K., Nishiyama K., Misumi K., Takazoe K., Miyao Y., Yoshimura M., Kugiyama K., Nakamura S., Tsuji I., Kumeda K. Heightened tissue factor associated with tissue factor pathway inhibitor and prognosis in patients with unstable angina. Circulation. 99:1999;2908-2913.
31. Levi M., ten Cate H., van der Poll T., Van Deventer S.J. Pathogenesis of disseminated intravascular coagulation in sepsis. JAMA J. Am. Med. Assoc. 270:1993;975-979.
32. Coughlin S.R. Sol Sherry lecture in thrombosis: how thrombin 'talks' to cells: molecular mechanisms and roles in vivo. Arterioscler. Thromb. Vasc. Biol. 18:1998;514-518.
33. Camerer E., Huang W., Coughlm S.R. Tissue factor- and factor X-dependent activation of protease-activated receptor 2 by factor VIIa. Proc. Natl. Acad. Sci. U. S. A. 97:2000;5255-5260.
34. Petersen L.C., Thastrup O., Hagel G., Sorensen O., Freskgard P.O., Rao L.V.M.et al. Exclusion of known protease activated receptors in factor VIIa-induced signal transduction. Thromb. Haemost. 83:2000;571-576.
35. Camerer E., Rottingen J.A., Gjernes E., Larsen K., Skartlien A.H., Iversen J.G. Coagulation factors VIIa and Xa induce cell signaling leading to up-regulation of the egr-l gene. J. Biol. Chem. 274:1999;32225-32233.
36. Taniguchi T., Kakkar A.K., Tuddenham E.G.D., Williamson R.C.N., Leinoine N.R. Enhanced expression of urokinase receptor induced through the tissue factor-factor VIIa pathway in human pancreatic cancer. Cancer Res. 58:1998;4461-4467.
37. Prydz H. A new paradigm for blood coagulation research. Thromb. Haemost. 83:2000;520-522.
38. Broze G.J. Jr. Tissue factor pathway inhibitor. Thromb. Haemost. 74:1995;90-93.
39. Broze G.J. Jr. Tissue factor pathway inhibitor and the current concept of blood coagulation. Blood Coagul. Fibrinolysis. 6(Suppl. 1):1995;S7-S13.
40. Hamik A., Setiadi H., Bo G.J., McEver R.P., Morrissey J.H. Down-regulation of monocyte tissue factor mediated by tissue factor pathway inhibitor and the low density lipoprotein receptor-related protein. J. Biol. Chem. 274:1999;4962-4969.
41. Sevinsky J.R., Rao L.V.M., Rut W. Ligand-induced protease receptor translocation into caveolae: a mechanism for regulating cell surface proteolysis of the tissue factor-dependent coagulation pathway. J. Cell. Biol. 133:1996;293-304.
42. Ott I., Miyagi Y., Miyazaki K., Heeb M.J., Mueller B.M., Rao L.V.M. Reversible regulation of tissue factor-induced coagulation by glycosyl phosphatidylinositol-anchored tissue factor pathway inhibitor. Arterioscler. Thromb. Vasc. Biol. 20:2000;874-882.
43. Haskel E.J., Torr S.R., Day K.C., Haskel E.J., Torr S.R., Day K.C., Palmier M.O., Wun T.C., Sobel B.E. Prevention of arterial reocclusion after thrombolysis with recombinant lipoprotein-associated coagulation inhibitor. Circulation. 84:1991;821-827.
44. Jang Y., Guzman L.A., Lincoff A.M., Gottsauner-Wolf M., Forudi F., Hart C.E., Courtman D.W., Ezban M., Ellis S.G., Topol E.J. Influence of blockade at specific levels of the coagulation cascade on restenosis in a rabbit atherosclerotic femoral artery injury model. Circulation. 92:1995;3041-3050.
45. Oltrona L., Speidel C.M., Recchia D., Wickline S.A., Eisenberg P.R., Abendschein D.R. Inhibition of tissue factor-mediated coagulation markedly attenuates stenosis after balloon-induced arterial injury in minipigs. Circulation. 96:1997;646-652.
46. St. Pierre J., Yang L.Y., Tamirisa K., Scherrer D., De Ciechi P., Eisenberg P., Tolunay E., Abdenschein D. Tissue factor pathway inhibitor attenuates procoagulant activity and upregulation of tissue factor at the site of balloon-induced arterial injury in pigs. Arterioscler. Thromb. Vasc. Biol. 19:1999;2263-2268.
47. Abraham E. Tissue factor inhibition and clinical trial results of tissue factor pathway inhibitor in sepsis. Crit. Care Med. 28:2000;831-833.
48. Golino P., Cirillo P., Calabrò P., Ragni M., D'Andrea D., Chiariello P. Expression of exogenous tissue factor pathway inhibitor in vivo suppresses thrombus formation in inured rabbit carotid arteries. J. Am. Coll. Cardiol. 38:2001;569-576.
49. Zoldhelyi P., Chen Z.Q., Shelat H.S., McNatt J.M., Willereson J.T. Local gene transfer of tissue factor pathway inhibitor regulates intimal hyperplasia in atherosclerotic arteries. Proc. Natl. Acad. Sci. 98:2000;4078-4083.
50. Atsuchi N., Nishida T., Marutsuka K., Asada Y., Kamikubo Y., Takeshita A., Ueno H. Combination of a brief irrigation with tissue factor pathway inhibitor (TFPI) and adenovirus-mediated local TFPI gene transfer additively reduces neointima formation in balloon-injured rabbit carotid arteries. Circulation. 103:2001;570-575.
51. Pawashe A.B., Golino P., Ambrosio G., Migliaccio F., Ragni M., Pascucci I., Chiariello M., Bach R., Garen A., Konigsberg W.K., Ezekowitz M.D. A monoclonal antibody against rabbit tissue factor inhibits thrombus formation in stenotic injured rabbit carotid arteries. Circ. Res. 74:1994;56-63.
52. Ragni M., Cirillo P., Pascucci I., Scognamiglio A., D'Andrea D., Eramo N., Ezekowitz M.D., Pawashe A.B., Chiariello M., Golino P. A monoclonal antibody against tissue factor shortens tissue-plasminogen activator lysis time and prevents reocclusion in a rabbit model of carotid artery thrombosis. Circulation. 93:1996;1913-1920.
53. Petersen L.C., Sprecher C.A., Foster D.C., Blumberg H., Hamamoto T., Kisiel W. Inhibitory properties of a novel human Kunitz-type protease inhibitor homologous to tissue factor pathway inhibitor. Biochemistry. 35:1996;266-272.
54. Kondo S., Kisiel W. Regulation of factor VIIa in plasma: evidence that antithrombin III is the sole plasma proteinase inhibitor of human factor VIIa. Thromb. Res. 46:1987;325-331.
55. Girard T.J., MacPhail L.A., Likert K.M., Novutny W.F., Miletich J.P., Bruze G.J. Jr. Inhibition of factor VIIa-tissue factor coagulation activity by a hybrid protein. Science. 248:1990;1421-1424.
56. Dennis M.S., Lazarus R.A. Kunitz domain inhibitors of tissue factor-factor VIIa: II. Potent and specific inhibitors by competitive phage selection. J. Biol. Chem. 269:1994;22137-22144.
57. Stassen J.M., Lambeir A.-M., Manhyssens G., Ripka W.C., Nystrom A., Sixma J.J. Characterization of a novel series of aprotinin-derived anticoagulants: I. In vitro and pharmacological properties. Thromb. Haemost. 74:1995;646-654.
58. Lee A., Agnelli G., Buller H., Ginsberg J., Heit J., Rote W., Vlasuk G., Costantini L., Julian J., Comp P., van del Meer J., Piovella F., Raskob G., Gent M. Dose-response study of recombinant factor VIIa/tissue factor inhibitor recombinant nematode anticoagulant protein c2 in the prevention of post-operative venous thromboembolism in patients undergoing total knee replacement. Circulation. 104:2000;74-78.
59. Harker L.A., Hanson S.R., Wilcox J.N., Kelly A.B. Antithrombotic and anti-lesion benefits without hemorrhagic risks by inhibiting tissue factor pathway. Haemostasis. 26:1996;76-82.
60. Himber B., Kirebbofer D., Riederer M., Tschopp T.B., Steiner B., Roux S.P. Dissociation of antithrombotic effect and bleeding time prolongation in rabbits by inhibiting tissue factor function. Thromb. Haemost. 78:1997;1142-1149.
61. Harker L.A. Therapeutic inhibition of thrombin activities, receptors, and production. Hematol./Oncol. Clin. North Am. 12:1998;1211-1230.
62. Golino P., Ragni M., Cirillo P., D'Andrea D., Scognamiglio A., Ravera A., Buono C., Ezban M., Corcione N., Vigorito F., Condorelli M., Chiariello M. Antithrombotic effects of recombinant human, active site-blocked Factor VIIa in a rabbit model of recurrent arterial thrombosis. Circ. Res. 82:1998;39-46.
63. Golino P., Cirillo P., D'Andrea D., Ragni M., Calabrò P., Ravera M., Tommasini P., Ezban M., Chiariello M. Long-term antithrombotic effects of human recombinant, active site-blocked factor VIIa in a chronic model of intravascular thrombosis. Circulation. 98:1999;I727. (Abstract).
64. Rao L.V.M., Ezban M. Active site-blocked activated factor VII as an effective antithrombotic agent: mechanism of action. Blood Coagul. Fibrinolysis. 11:2000;S135-S143.